Pfizer starts Phase 2/3 clinical study to evaluate safety, efficacy of COVID-19 oral treatment in pediatric population

Mar 09, 2022

Washington [US], March 9 : Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate...

Pfizer-BioNTech COVID-19 vaccine protection lasts at least 'six months', protects against variants

Apr 01, 2021

New York [US], April 1 : The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine has confirmed its protection lasts at least six...

FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen

May 23, 2022

Malvern (Pennsylvania) [US], May 23 : Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold...

Glenmark announces top-line results from phase 3 clinical trial of Favipiravir in patients with mild to moderate COVID-19

Jul 23, 2020

Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical...

CliniExperts Successfully Completes Phase IV Akynzeo® I.V Study for Glenmark

Nov 28, 2025

New Delhi [India], November 28: CliniExperts Research Services Pvt. Ltd., New Delhi, India proudly announces the successful completion of Phase IV study on Akynzeo®...

Pfizer begins early stage trial for oral COVID-19 drug

Mar 24, 2021

New York [US], March 24 : Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.